Avoro Capital Advisors LLC Assembly Biosciences, Inc. Transaction History

Avoro Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $11.6 Million - $18.7 Million	-900,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$17.7 - $24.93 $1.77 Million - $2.49 Million	-100,000 Reduced 10.0%	900,000 $17.7 Million
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $922,534 - $1.77 Million	-48,427 Reduced 4.62%	1,000,000 $22.6 Million
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $2.92 Million - $3.76 Million	85,000 Added 8.82%	1,048,427 $38.9 Million
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $5.12 Million - $6.56 Million	-130,507 Reduced 11.93%	963,427 $37.8 Million
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $1.06 Million - $1.63 Million	25,400 Added 2.38%	1,093,934 $53.8 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $4.61 Million - $8.05 Million	161,372 Added 17.79%	1,068,534 $48.4 Million
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $20.9 Million - $31.7 Million	907,162	907,162 $31.7 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $765M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.